enavatuzumab (104)

Structure	 

Heavy chain / Chaone lourde / Cadena pesada

EVQLVESGGG LVQPGGSLRL SCAASGFTFS SYWMSWVRQA PGKGLEWVAE  50

IRLKSDNYAT HYAESVKGRF TISRDDSKNS LYLQMNSLRA EDTAVYYCTG 100

YYADAMDYWG QGTLVTVSSA STKGPSVFPL APSSKSTSGG TAALGCLVKD 150

YFPEPVTVSW NSGALTSGVH TFPAVLQSSG LYSLSSVVTV PSSSLGTQTY 200

ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPELLGGP SVFLFPPKPK 250

DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS 300

TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV 350

YTLPPSREEM TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL 400

DSDGSFFLYS KLTVDKSRWQ QGNVFSCSVM HEALHNHYTQ KSLSLSPGK  449

Light chain / Chaone lygire / Cadena ligera

DIQMTQSPSS LSASVGDRVT ITCRASQSVS TSSYSYMHWY QQKPGKAPKL  50

LIKYASNLES GVPSRFSGSG SGTDFTLTIS SLQPEDFATY YCQHSWEIPY 100

TFGGGTKVEI KRTVAAPSVF IFPPSDEQLK SGTASVVCLL NNFYPREAKV 150

QWKVDNALQS GNSQESVTEQ DSKDSTYSLS STLTLSKADY EKHKVYACEV 200

THQGLSSPVT KSFNRGEC                                    218

Disulfide bridges location / Position des ponts disulfure / Posiciones
de los puentes disulfuro

Intra-H	22-98	146-202	263-323	369-427

	22??-98??	146??-202??	263??-323??	369??-427??

Intra-L	23?-92?	138?-198?



	23???-92???	138???-198???



Inter-H-L	222-218?	222??-218???



Inter-H-H	228-228??	231-231??





N-glycosylation sites / Sites de N-glycosylation / Posiciones de
N-glicosilaciun

299, 299??

	

WHO 

International Nonproprietary Names Programme	

9354

31/01/2011

		

